File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Conference Paper: Comparison of post-treatment plasma EBV DNA with nasopharyngeal biopsy in patients after radical (chemo) radiotherapy for non-metatatic nasopharyngeal cancer

TitleComparison of post-treatment plasma EBV DNA with nasopharyngeal biopsy in patients after radical (chemo) radiotherapy for non-metatatic nasopharyngeal cancer
Authors
Lee, VHKwong, DLWLam, KOSze, HCKHo, PPYChan, WWLLeung, DKCWong, LSLeung, TW
KeywordsMedical sciences
Radiology and nuclear medicine
Issue Date2014
PublisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/ijrobp
Citation
The 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2014), San Francisco, CA., 14–17 September 2014. In International Journal of Radiation: Oncology - Biology - Physics, 2014, v. 90 n. 1 suppl., p. S120, abstract no. 261 How to Cite?
DOI: http://dx.doi.org/10.1016/j.ijrobp.2014.05.554
AbstractPURPOSE/OBJECTIVE(S): Random nasopharyngeal biopsy after completion of intensity-modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal cancer (NPC) is routinely practiced in Hong Kong to confirm local remission. Plasma EBV DNA is proven an accurate marker for NPC. We carried out a prospective study comparing the correlation between post-IMRT nasopharyngeal biopsy and EBV DNA, to investigate if EBV DNA can substitute biopsy to confirm local remission. MATERIALS/METHODS: Patients with non-metastatic NPC treated with definitive (chemo) IMRT diagnosed between January 2011 and March 2013 were recruited. After baseline workup ...
DescriptionThis journal suppl. entitled: Proceedings of the American Society for Radiation Oncology 56th Annual Meeting, ASTRO's 56th Annual Meeting ... 2014
Oral Scientific Session
Persistent Identifierhttp://hdl.handle.net/10722/204425
ISSN
0360-3016
2021 Impact Factor: 8.013
2020 SCImago Journal Rankings: 2.117
ISI Accession Number ID
WOS:000342331400273

 

DC FieldValueLanguage
dc.contributor.authorLee, VHen_US
dc.contributor.authorKwong, DLWen_US
dc.contributor.authorLam, KOen_US
dc.contributor.authorSze, HCKen_US
dc.contributor.authorHo, PPYen_US
dc.contributor.authorChan, WWLen_US
dc.contributor.authorLeung, DKCen_US
dc.contributor.authorWong, LSen_US
dc.contributor.authorLeung, TWen_US
dc.date.accessioned2014-09-19T23:45:35Z-
dc.date.available2014-09-19T23:45:35Z-
dc.date.issued2014en_US
dc.identifier.citationThe 56th Annual Meeting of the American Society for Radiation Oncology (ASTRO 2014), San Francisco, CA., 14–17 September 2014. In International Journal of Radiation: Oncology - Biology - Physics, 2014, v. 90 n. 1 suppl., p. S120, abstract no. 261en_US
dc.identifier.issn0360-3016-
dc.identifier.urihttp://hdl.handle.net/10722/204425-
dc.descriptionThis journal suppl. entitled: Proceedings of the American Society for Radiation Oncology 56th Annual Meeting, ASTRO's 56th Annual Meeting ... 2014-
dc.descriptionOral Scientific Session-
dc.description.abstractPURPOSE/OBJECTIVE(S): Random nasopharyngeal biopsy after completion of intensity-modulated radiation therapy (IMRT) for non-metastatic nasopharyngeal cancer (NPC) is routinely practiced in Hong Kong to confirm local remission. Plasma EBV DNA is proven an accurate marker for NPC. We carried out a prospective study comparing the correlation between post-IMRT nasopharyngeal biopsy and EBV DNA, to investigate if EBV DNA can substitute biopsy to confirm local remission. MATERIALS/METHODS: Patients with non-metastatic NPC treated with definitive (chemo) IMRT diagnosed between January 2011 and March 2013 were recruited. After baseline workup ...-
dc.languageengen_US
dc.publisherElsevier Inc. The Journal's web site is located at http://www.elsevier.com/locate/ijrobpen_US
dc.relation.ispartofInternational Journal of Radiation: Oncology - Biology - Physicsen_US
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectMedical sciences-
dc.subjectRadiology and nuclear medicine-
dc.titleComparison of post-treatment plasma EBV DNA with nasopharyngeal biopsy in patients after radical (chemo) radiotherapy for non-metatatic nasopharyngeal canceren_US
dc.typeConference_Paperen_US
dc.identifier.emailLee, VH: vhflee@hku.hken_US
dc.identifier.emailKwong, DLW: dlwkwong@hku.hken_US
dc.identifier.emailLam, KO: lamkaon@hku.hken_US
dc.identifier.emailSze, HCK: henrysze@graduate.hku.hken_US
dc.identifier.emailLeung, TW: ltw920@hkucc.hku.hken_US
dc.identifier.authorityLee, VH=rp00264en_US
dc.identifier.authorityKwong, DLW=rp00414en_US
dc.identifier.authorityLam, KO=rp01501en_US
dc.identifier.authoritySze, HCK=rp01697en_US
dc.description.naturepostprint-
dc.identifier.doi10.1016/j.ijrobp.2014.05.554-
dc.identifier.hkuros237809en_US
dc.identifier.volume90-
dc.identifier.issue1 suppl.-
dc.identifier.spageS120, abstract no. 261-
dc.identifier.epageS120, abstract no. 261-
dc.identifier.isiWOS:000342331400273-
dc.publisher.placeUnited Statesen_US
dc.identifier.issnl0360-3016-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats